Skip to main navigation
Skip to search
Skip to main content
Search All UT System Experts
University of Texas Southwestern Medical Center Home
Home
Profiles
Research units
Equipment
Research output
Search by expertise, name or affiliation
Cetuximab in combination therapy: From bench to clinic
David E. Gerber
,
Hak Choy
Hematology & Oncology
Internal Medicine
Radiation Oncology
Radiation Oncology - Administration
Research output
:
Contribution to journal
›
Review article
›
peer-review
25
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Cetuximab in combination therapy: From bench to clinic'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
Cetuximab
100%
Head and Neck Neoplasms
64%
Drug Therapy
28%
Colorectal Neoplasms
25%
Lung Neoplasms
25%
Radiotherapy
22%
Oxaliplatin
18%
Irinotecan
18%
Cytotoxins
17%
Survival
17%
Cell Cycle Checkpoints
15%
ErbB Receptors
15%
DNA Repair
14%
Therapeutics
13%
Immunoglobulin G
12%
Monoclonal Antibodies
11%
Ligands
11%
Cell Proliferation
10%
Clinical Trials
10%
Biomarkers
10%
Neoplasms
10%
Apoptosis
9%